In recent years, the total annual sales of the global vaccine market have remained around $30 billion. Antibody drugs are the main force of the modern biopharmaceutical industry, currently accounting for 50% of the global biopharmaceutical market, is the fastest growing segment of the biopharmaceutical industry.
In today's increasingly accelerated globalization, vaccine and antibody research and development, quality technology as a key field to protect human health, its development and innovation is particularly important.
China (Beijing) International Development Forum on Vaccine and Antibody Innovation，Was born to drive progress in this field. The forum will bring together top researchers, business leaders and experts and scholars to discuss and analyze industry trends, policy standards and market trends. Let us write a new chapter in vaccine and antibody research and development, quality technology, and make greater contributions to the health and well-being of all mankind!
Meeting time：January 25-26, 2024
Meeting place：Beijing Fengda International Hotel
Participants
Invited universities, research institutes, domestic and foreign experts and famous scholars, antibody research and development centers, research institutes, key laboratory leaders, vaccine production executives, cell therapy executives, then 1000 people gathered in Beijing
Booth information: ASHMAR Booth No. 16
Agenda of the conference
掃描二維碼，關(guān)注我們
